Abstract
We studied the impact of FK506, a potent immunosuppressant, on graft coronary disease and graft-infiltrating lymphocyte subset after rat heart transplantation. Fisher rat heart grafts transplanted into Lewis rat recipients were divided into three groups: control (n = 7), rats treated with FK506 at a dose of 0.32 mg/kg/day intramuscularly (n = 7), and rats treated with cyclosporine at a dose of 10 mg/kg/day intramuscularly (n = 7). Grafts were removed on day 71 in the treated groups and on rejection in the control group. We blindly scored graft rejection and graft coronary disease on a scale of 0 to 4. Graft-infiltrating lymphocytes were investigated by flow- cytometric analysis with the following monoclonal antibodies: W3/25, anti- helper T lymphocyte; OX8, antisuppressor and cytotoxic T lymphocyte; and OX39, antiinterleukin-2 receptor. No difference of graft rejection was found between the two treated groups (FK506 1.66 ± 0.49 versus cyclosporine 1.45 ± 0.37), but the FK506 group showed severe graft coronary disease (FK506 2.14 ± 0.82 versus cyclosporine 0.78 ± 0.17; p <0.01) in this model. In flow-cytometric analysis, we found an increased proportion of OX8-positive lymphocytes (FK506 25.7 ± 6.4 versus cyclosporine 4.9 ± 2.4, p <0.01). These results suggest that suppression of cytotoxic T lymphocytes may be involved in graft coronary disease.
| Original language | English |
|---|---|
| Pages (from-to) | 757-762 |
| Number of pages | 6 |
| Journal | Journal of Heart and Lung Transplantation |
| Volume | 11 |
| Issue number | 4 I |
| Publication status | Published - 1992 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Surgery
- Transplantation
Cite this
The impact of FK506 on graft coronary disease of rat cardiac allograft - A comparison with cyclosporine. / Arai, Sadahiko; Teramoto, S.; Senoo, Y.
In: Journal of Heart and Lung Transplantation, Vol. 11, No. 4 I, 1992, p. 757-762.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The impact of FK506 on graft coronary disease of rat cardiac allograft - A comparison with cyclosporine
AU - Arai, Sadahiko
AU - Teramoto, S.
AU - Senoo, Y.
PY - 1992
Y1 - 1992
N2 - We studied the impact of FK506, a potent immunosuppressant, on graft coronary disease and graft-infiltrating lymphocyte subset after rat heart transplantation. Fisher rat heart grafts transplanted into Lewis rat recipients were divided into three groups: control (n = 7), rats treated with FK506 at a dose of 0.32 mg/kg/day intramuscularly (n = 7), and rats treated with cyclosporine at a dose of 10 mg/kg/day intramuscularly (n = 7). Grafts were removed on day 71 in the treated groups and on rejection in the control group. We blindly scored graft rejection and graft coronary disease on a scale of 0 to 4. Graft-infiltrating lymphocytes were investigated by flow- cytometric analysis with the following monoclonal antibodies: W3/25, anti- helper T lymphocyte; OX8, antisuppressor and cytotoxic T lymphocyte; and OX39, antiinterleukin-2 receptor. No difference of graft rejection was found between the two treated groups (FK506 1.66 ± 0.49 versus cyclosporine 1.45 ± 0.37), but the FK506 group showed severe graft coronary disease (FK506 2.14 ± 0.82 versus cyclosporine 0.78 ± 0.17; p <0.01) in this model. In flow-cytometric analysis, we found an increased proportion of OX8-positive lymphocytes (FK506 25.7 ± 6.4 versus cyclosporine 4.9 ± 2.4, p <0.01). These results suggest that suppression of cytotoxic T lymphocytes may be involved in graft coronary disease.
AB - We studied the impact of FK506, a potent immunosuppressant, on graft coronary disease and graft-infiltrating lymphocyte subset after rat heart transplantation. Fisher rat heart grafts transplanted into Lewis rat recipients were divided into three groups: control (n = 7), rats treated with FK506 at a dose of 0.32 mg/kg/day intramuscularly (n = 7), and rats treated with cyclosporine at a dose of 10 mg/kg/day intramuscularly (n = 7). Grafts were removed on day 71 in the treated groups and on rejection in the control group. We blindly scored graft rejection and graft coronary disease on a scale of 0 to 4. Graft-infiltrating lymphocytes were investigated by flow- cytometric analysis with the following monoclonal antibodies: W3/25, anti- helper T lymphocyte; OX8, antisuppressor and cytotoxic T lymphocyte; and OX39, antiinterleukin-2 receptor. No difference of graft rejection was found between the two treated groups (FK506 1.66 ± 0.49 versus cyclosporine 1.45 ± 0.37), but the FK506 group showed severe graft coronary disease (FK506 2.14 ± 0.82 versus cyclosporine 0.78 ± 0.17; p <0.01) in this model. In flow-cytometric analysis, we found an increased proportion of OX8-positive lymphocytes (FK506 25.7 ± 6.4 versus cyclosporine 4.9 ± 2.4, p <0.01). These results suggest that suppression of cytotoxic T lymphocytes may be involved in graft coronary disease.
UR - http://www.scopus.com/inward/record.url?scp=0026781512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026781512&partnerID=8YFLogxK
M3 - Article
C2 - 1379829
AN - SCOPUS:0026781512
VL - 11
SP - 757
EP - 762
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
SN - 1053-2498
IS - 4 I
ER -